We could not find any results for:
Make sure your spelling is correct or try broadening your search.
/newsletter/barneyc/769/abundant-produce-limited-show-promising-growth
ABBOTT PARK, Ill., Jan. 4 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) will present at the 28th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 11, 2010. Thomas C. Freyman, executive...
ABBOTT PARK, Ill., Jan. 4 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) will announce its fourth-quarter and full-year 2009 financial results on Wednesday, Jan. 27, 2010, before the market...
ABBOTT PARK, Ill., Dec. 11 /PRNewswire-FirstCall/ -- The board of directors of Abbott (NYSE:ABT) today declared a quarterly common dividend of 40 cents per share. This marks the 344th...
ABBOTT PARK, Ill., Nov. 12 /PRNewswire-FirstCall/ -- Nearly one in three adult Americans have triglyceride (trig) levels that are above normal and nearly 34 million have low HDL "good...
By Jon Kamp Of DOW JONES NEWSWIRES Hospira Inc.'s (HSP) third-quarter profit jumped 42% as results surged ahead of analysts' expectations with help from a generic version of a Sanofi-Aventis SA...
By Peter Loftus Of DOW JONES NEWSWIRES A European regulatory body plans to examine whether certain cholesterol drugs have long-term clinical benefits--and one potential outcome could be their...
Chicago Council on Global Affairs and Abbott sponsor the inaugural event of 'The Women and Global Development Forum' with CARE's Dr. Helene Gayle CHICAGO, Oct. 20 /PRNewswire/ -- CARE is pleased...
The U.S. Food and Drug Administration on Monday said it is investigating whether certain medical device power cords are defective, after receiving more than 100 reports of power cord failures from...
(Updates stock price in 3rd paragraph; adds analyst reaction beginning in 4th graph; comment from CFO in 18th graph.) By Peter Loftus Of DOW JONES NEWSWIRES Abbott Laboratories (ABT) reported a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | -0.033 | -55 | 0.06 | 0.068 | 0.01 | 189381 | 0.02487601 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions